Nishimura T - Search Results

1

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

Tsuji T, Yasukawa M, Matsuzaki J, Ohkuri T, Chamoto K, Wakita D, Azuma T, Niiya H, Miyoshi H, Kuzushima K, Oka Y, Sugiyama H, Ikeda H, Nishimura T. Tsuji T, et al. Among authors: nishimura t. Blood. 2005 Jul 15;106(2):470-6. doi: 10.1182/blood-2004-09-3663. Epub 2005 Mar 24. Blood. 2005. PMID: 15790789 Free article.

2

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.

Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Nishimura T, et al. J Exp Med. 1999 Sep 6;190(5):617-27. doi: 10.1084/jem.190.5.617. J Exp Med. 1999. PMID: 10477547 Free PMC article.

3

The influence of dietary protein antigen on Th1/Th2 balance and cellular immunity.

Sato M, Iwakabe K, Kimura S, Nishimura T. Sato M, et al. Among authors: nishimura t. Immunol Lett. 1999 Oct 1;70(1):29-35. doi: 10.1016/s0165-2478(99)00122-4. Immunol Lett. 1999. PMID: 10541049

4

Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody.

Ohmi Y, Shiku H, Nishimura T. Ohmi Y, et al. Among authors: nishimura t. Cancer Immunol Immunother. 1999 Nov;48(8):456-62. doi: 10.1007/s002620050622. Cancer Immunol Immunother. 1999. PMID: 10550550 Free PMC article.

5

Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen.

Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y, Sekikawa K, Nishimura T. Ohta A, et al. Among authors: nishimura s, nishimura t. J Immunol. 2000 Jul 15;165(2):956-61. doi: 10.4049/jimmunol.165.2.956. J Immunol. 2000. PMID: 10878371

6

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T. Nishimura T, et al. Int Immunol. 2000 Jul;12(7):987-94. doi: 10.1093/intimm/12.7.987. Int Immunol. 2000. PMID: 10882410

7

The critical role of Th1-dominant immunity in tumor immunology.

Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T, Nishimura S. Nishimura T, et al. Among authors: nishimura s. Cancer Chemother Pharmacol. 2000;46 Suppl:S52-61. doi: 10.1007/pl00014051. Cancer Chemother Pharmacol. 2000. PMID: 10950149

8

Th1 cytokine-conditioned bone marrow-derived dendritic cells can bypass the requirement for Th functions during the generation of CD8+ CTL.

Sato M, Chamoto K, Tsuji T, Iwakura Y, Togashi Y, Koda T, Nishimura T. Sato M, et al. Among authors: nishimura t. J Immunol. 2001 Oct 1;167(7):3687-91. doi: 10.4049/jimmunol.167.7.3687. J Immunol. 2001. PMID: 11564783

9

Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets.

Sasaki K, Tsuji T, Jinushi T, Matsuzaki J, Sato T, Chamoto K, Togashi Y, Koda T, Nishimura T. Sasaki K, et al. Among authors: nishimura t. Int Immunol. 2003 Jun;15(6):701-10. doi: 10.1093/intimm/dxg066. Int Immunol. 2003. PMID: 12750354

10

A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells.

Sato M, Chamoto K, Nishimura T. Sato M, et al. Among authors: nishimura t. Int Immunol. 2003 Jul;15(7):837-43. doi: 10.1093/intimm/dxg081. Int Immunol. 2003. PMID: 12807822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,251 results

Search Page

Filters